Erin Boyer
Oficial de Recursos Humanos en UNIQURE N.V. .
Cargos activos de Erin Boyer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| UNIQURE N.V. | Oficial de Recursos Humanos | 01/04/2022 | - |
Historial de carrera de Erin Boyer
Antiguos cargos conocidos de Erin Boyer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Oficial de Recursos Humanos | - | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
| EPIZYME, INC. | Oficial de Recursos Humanos | 01/11/2020 | - |
Formación de Erin Boyer.
| Macalester College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Países Bajos | 2 |
Operativa
| Human Resources Officer | 3 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| UNIQURE N.V. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Erin Boyer
- Experiencia
